Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Latest news from Datamonitor

July 23, 2007 Research and Development, Sales and Marketing

Affiris begins clinical testing of Alzheimer's vaccineAffiris' Alzheimer's vaccine Affitope has now entered the clinical phase of its development and …
News

Latest news from Datamonitor

July 16, 2007 Research and Development, Sales and Marketing

Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
News

Time is money in R&D

July 16, 2007 Research and Development clincial trials, drug development, productivity

There is a much-quoted statistic, which has become so hackneyed that it's largely ignored these days, but while you are …
Feature

Piramed and Domainex named among best of British biotech

July 12, 2007 Research and Development Piramed, domainex

Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …
News

Latest news from Datamonitor

July 9, 2007 Research and Development, Sales and Marketing

Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
News

Latest news from Datamonitor

July 2, 2007 Research and Development

Biovest reports encouraging interim results for cancer vaccineBiovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has revealed positive interim data …
News

Clinical Trials: The future is hub-shaped

July 2, 2007 Research and Development clinical trials, design

The global clinical trials market continues to grow and is currently worth an estimated $10 billion; so much so that …
Feature

Roche strengthens autoimmune franchise with arthritis drug deal

June 28, 2007 Research and Development, Sales and Marketing

Roche has added a novel treatment for rheumatoid arthritis to its early stage pipeline, one it says has the potential …
News

Latest news from Datamonitor

June 22, 2007 Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …
News

GSK commits milions of pounds to new imaging centre

June 21, 2007 Research and Development

The largest new imaging centre in Europe – an £83 million collaboration between GlaxoSmithKline (GSK), Imperial College London and the …
News

GSK highlights new oncology drugs

June 20, 2007 Research and Development

GlaxoSmithKline has provided investors with details of a number of new oncology drugs it aims to launch over the next …
News

Latest news from Datamonitor

June 8, 2007 Research and Development, Sales and Marketing

Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …
News

Scientists hail new gene discovery a landmark

June 7, 2007 Research and Development

DNA samples from 17,000 people across the UK have helped a consortium of scientists to pinpoint genes responsible for diseases …
News

Quintiles invests

June 7, 2007 Research and Development

Contract research organisation Quintiles is to spend £7.5 million (€11 million) on a new home for its Scottish product development …
News

Amgen boosts pipeline with spending spree

June 7, 2007 Research and Development, Sales and Marketing

Amgen has spent $720 million acquiring two US biotech companies in deals that add potential treatments for diabetes and kidney …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026